Skip to content
SalamTechs
العربيةBusiness services

Scopio Labs develops full-field digital imaging and analysis tools for hematology laboratories.

Introduce me to Scopio Labs
Scopio Labs website sharing image

Image source: company website sharing image

Founders & company facts

Sources reviewed:

Reported cumulative funding

$140,000,000 · Source

This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .

Documented founding team

Founded
2014Source
Reported Israeli location
Tel Aviv-YafoSource
Team range in directory
51-200Source
Reported business model
B2BSource

Selected disclosed financing

Selected transactions, with dates, funding types and reported participants.

  1. Jul 2025$10MSeries D
    Named participants

    Viola Growth

    Source
  2. Jul 2024$42MSeries D
    Named participants

    Fortissimo Capital · Aescuvest · XB Ventures

    Source

Company overview

Product & customers

Scopio Labs develops full-field digital imaging and analysis tools for hematology laboratories. Its platform lets specialists review blood-cell morphology on screen and share digitised slides, supporting laboratory workflows that have traditionally relied on direct microscopy.

Commercial potential · editorial analysis

Digitisation can enable remote specialist review and more consistent workflows across laboratory networks. The business potential rests on combining hardware placement with sustained software use and practical improvements in the handling of everyday samples.

What to validate

Check validation for each application, throughput, image quality and relevant approvals. Instrument economics, maintenance, integration with laboratory systems and the availability of trained reviewers determine whether adoption translates into repeatable commercial value.

Explore the company website

Product source reviewed on . Company source